FDA Inspection of Emcure's API Facility Results in Form 483; Relonchem Gains UK Approval for Pain Relief Combination
Emcure Pharmaceuticals' API manufacturing facility in Maharashtra underwent a week-long USFDA cGMP inspection, resulting in two Form 483 observations.
© Copyright 2025. All Rights Reserved by MedPath